Preliminary clinical evaluation of leuprorelin acetate depot injection in France, in the management of prostatic cancer.

  • Henri Navratil
  • Published 1990 in The Journal of international medical research

Abstract

In a preliminary multicentre clinical trial of 3.75 mg leuprorelin acetate depot 18 previously untreated patients with metastatic prostatic cancer were treated with the depot given subcutaneously once every 4 weeks for 28 weeks. Patients also received 100 mg nilutamide taken orally three times a day for the first 14 days of treatment to prevent flare-up… (More)

Topics

  • Presentations referencing similar topics